RIO DE JANEIRO, BRAZIL - The National Health Regulatory Agency (ANVISA) issued an alert on Friday, June 5th, about the increase in cases of falsification of medicinal products in Brazil in the first months of 2020. Among the counterfeits are drugs used to treat hepatitis C, flu vaccine, and drugs for growth disorders, obesity, and diabetes.
According to the agency, the increase in monitoring, coupled with the increase of online purchases during the novel coronavirus pandemic, are among the reasons for the rise in such occurrences.
The agency announced that five cases were recorded this year compared to three in 2018 . . .